|
Volumn 29, Issue 10, 2011, Pages 852-
|
HIV drugs made in tobacco.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
MONOCLONAL ANTIBODY;
BIOSYNTHESIS;
CLINICAL TRIAL (TOPIC);
DRUG INDUSTRY;
EUROPE;
GENETICS;
HUMAN;
IMMUNOLOGY;
METABOLISM;
NOTE;
TOBACCO;
TRANSGENIC PLANT;
AIDS VACCINES;
ANTI-HIV AGENTS;
ANTIBODIES, MONOCLONAL;
CLINICAL TRIALS AS TOPIC;
DRUG INDUSTRY;
EUROPE;
HUMANS;
PLANTS, GENETICALLY MODIFIED;
TOBACCO;
|
EID: 84856404226
PISSN: None
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt1011-852 Document Type: Note |
Times cited : (6)
|
References (0)
|